{
    "applicationNumber": "BR 11 2018 000410-3",
    "filingDate": "08/07/2016",
    "grantDate": null,
    "title": "DERIVADOS DE EXENDINA-4 COMO AGONISTAS PEPT\u00cdDICOS SELETIVOS DUPLOS DOS RECEPTORES DE GLP-1 / GLUCAGON",
    "nationalPhaseDate": [
        "08/01/2018"
    ],
    "internationalApplication": {
        "pctNumber": "PCT EP2016/066299",
        "pctDate": "08/07/2016",
        "wipoNumber": null,
        "wipoDate": null
    },
    "priorityClaims": [
        {
            "countryCode": "EP",
            "priorityNumber": "15306141.1",
            "priorityDate": "10/07/2015"
        }
    ],
    "events": [
        {
            "code": "1.3",
            "description": "Notifica\u00e7\u00e3o - Fase Nacional - PCT",
            "bulletinNumber ": "2491"
        },
        {
            "code": "11.1",
            "description": "Arquivamento - Art. 33 da LPI",
            "bulletinNumber ": "2533"
        },
        {
            "code": "11.1.1",
            "description": "Arquivamento definitivo - Art. 33 da LPI",
            "bulletinNumber ": "2544"
        }
    ],
    "inventors": [
        "MARTIN BOSSART",
        "ANDREAS EVERS",
        "TORSTEN HAACK",
        "KATRIN LORENZ",
        "DIETER KADEREIT",
        "MICHAEL WAGNER",
        "BERND HENKEL"
    ],
    "holders": [
        79177
    ],
    "ipcCodes": [
        "C07K 14/435"
    ]
}